Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A 17-gene stemness score for rapid determination of risk in acute leukaemia
Stanley Ng, Amanda Mitchell, Theodore A. Kennedy, et al.
Nature (2016) Vol. 540, Iss. 7633, pp. 433-437
Closed Access | Times Cited: 745

Showing 1-25 of 745 citing articles:

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta, Artem Sokolov, Andrew J. Gentles, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 338-354.e15
Open Access | Times Cited: 1741
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
Ashraful Haque, Jessica A. Engel, Sarah A. Teichmann, et al.
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 897
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Peter van Galen, Volker Hovestadt, Marc H. Wadsworth, et al.
Cell (2019) Vol. 176, Iss. 6, pp. 1265-1281.e24
Open Access | Times Cited: 872
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge, Estelle Saland, Fabienne de Toni, et al.
Cancer Discovery (2017) Vol. 7, Iss. 7, pp. 716-735
Open Access | Times Cited: 724
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1859-1866
Open Access | Times Cited: 587
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Liran I. Shlush, Amanda Mitchell, Lawrence E. Heisler, et al.
Nature (2017) Vol. 547, Iss. 7661, pp. 104-108
Closed Access | Times Cited: 497
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Caner Saygin, Daniela Matei, Ravindra Majeti, et al.
Cell stem cell (2018) Vol. 24, Iss. 1, pp. 25-40
Open Access | Times Cited: 453
Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Alex Miranda, Phineas T. Hamilton, Allen W. Zhang, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 18, pp. 9020-9029
Open Access | Times Cited: 449
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
J Paris, Marcos Morgan, Joana Campos, et al.
Cell stem cell (2019) Vol. 25, Iss. 1, pp. 137-148.e6
Open Access | Times Cited: 401
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
Shanshan Pei, Daniel A. Pollyea, Annika Gustafson, et al.
Cancer Discovery (2020) Vol. 10, Iss. 4, pp. 536-551
Open Access | Times Cited: 371
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Anna Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
Nature (2019) Vol. 572, Iss. 7768, pp. 254-259
Open Access | Times Cited: 309
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Simon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature (2017) Vol. 551, Iss. 7680, pp. 384-388
Closed Access | Times Cited: 296
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Carsten Bahr, Lisa von Paleske, Veli Vural Uslu, et al.
Nature (2018) Vol. 553, Iss. 7689, pp. 515-520
Closed Access | Times Cited: 291
Quantitative single-cell proteomics as a tool to characterize cellular hierarchies
Erwin M. Schoof, Benjamin Furtwängler, Nil Üresin, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 287
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
David Vetrie, G. Vignir Helgason, Mhairi Copland
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 158-173
Open Access | Times Cited: 264
Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
Sipeng Shen, Guanrong Wang, Ruyang Zhang, et al.
EBioMedicine (2018) Vol. 40, pp. 318-326
Open Access | Times Cited: 235
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Cell stem cell (2018) Vol. 23, Iss. 1, pp. 86-100.e6
Open Access | Times Cited: 233
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
Irène Baccelli, Yves Gareau, Bernhard Lehnertz, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 84-99.e8
Open Access | Times Cited: 202
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Daniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Cancer Cell (2022) Vol. 40, Iss. 8, pp. 850-864.e9
Open Access | Times Cited: 196
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Andy G.X. Zeng, Suraj Bansal, Liqing Jin, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1212-1223
Open Access | Times Cited: 193
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Cihangir Duy, Meng Li, Matt Teater, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1542-1561
Open Access | Times Cited: 176
CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia
Wendelien Zeijlemaker, Tim Grob, Rosa Meijer, et al.
Leukemia (2018) Vol. 33, Iss. 5, pp. 1102-1112
Closed Access | Times Cited: 175
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu, Mark D. Minden, Tressa Hood, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 546
Open Access | Times Cited: 170
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
Charles C. Bell, Katie Fennell, Yih-Chih Chan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 153
CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells
Christine Surka, Liqing Jin, Nathan Mbong, et al.
Blood (2020) Vol. 137, Iss. 5, pp. 661-677
Open Access | Times Cited: 152
Page 1 - Next Page

Scroll to top